SEC Form 5 · accession 0001567619-19-003878
OncoMed Pharmaceuticals Inc · OMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yvonne Li
Officer — See Remarks
Period of report
Dec 31, 2018
Accepted (ET)
Feb 13, 2019 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573
Table I — non-derivative securities
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 17,403 shares which were inadvertently omitted from the Reporting Person's Form 3 filing on March 20, 2018.
- F2Includes 27,501 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
Remarks
Vice President, Finance, Controller and Administration